Vascular parkinsonism in a CADASIL case with an intact nigrostriatal dopaminergic system [2]

Journal of Neurology

Volumn 254, Issue 12, 2007, Pages 1743-1745

  Wegner, F ^a   Strecker, K ^a   Schwarz, J ^a   Wagner, A ^a   Heinritz, W ^a   Sommerer, F ^a   Thal, D R ^b   Schneider, J P ^a   Kendziorra, K ^a   Sabri, O ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ATORVASTATIN; BENSERAZIDE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; FLUORODEOXYGLUCOSE F 18; LEVODOPA; RIVASTIGMINE;

ADULT; BRAIN FUNCTION; CADASIL; CASE REPORT; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINERGIC SYSTEM; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG HALF LIFE; ELECTRON MICROSCOPY; FATIGUE; HISTOPATHOLOGY; HUMAN; HYPERLIPIDEMIA; LETTER; MALE; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NEUROLOGIC EXAMINATION; NIGRONEOSTRIATAL SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SKIN BIOPSY; URINE INCONTINENCE;

CADASIL; CORPUS STRIATUM; DOPAMINE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE, SECONDARY; SKIN; SUBSTANTIA NIGRA;

EID: 37749029377     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-007-0529-4     Document Type: Letter

References (10)

1. Ringelstein EB, Nabavi DG (2005) Cerebral small vessel diseases: cerebral microangiopathies. Curr Opin Neurol 18:179-188
2. Dichgans M, Mayer M, Uttner I, Bruning R, Muller-Hocker J, Rungger G, Ebke M, Klockgether T, Gasser T (1998) The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 44:731-739
3. Günther P, Storch A, Schwarz J, Sabri O, Steinbach P, Wagner A, Hesse S (2004) Basal ganglia involvement of a patient with SCA 17 - a new form of autosomal dominant spinocerebellar ataxia. J Neurol 251:896-897
4. Ruchoux MM, Guerouaou D, Vandenhaute B, Pruvo JP, Vermersch P, Leys D (1995) Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukencephalopathy. Acta Neuropathol (Berl) 89:500-512
5. Peters N, Opherk C, Bergmann T, Castro M, Herzog J, Dichgans M (2005) Spectrum of mutations in biopsyproven CADASIL: implications for diagnostic strategies. Arch Neurol 62:1091-1094
6. Markus HS, Martin RJ, Simpson MA, Dong YB, Ali N, Crosby AH, Powell JF (2002) Diagnostic strategies in CADASIL. Neurology 59:1134-1138
7. Van Gerpen JA, Ahlskog JE, Petty GW (2003) Progressive supranuclear palsy phenotype secondary to CADASIL. Parkinsonism Relat Disord 9:367-369
8. Thanvi B, Lo N, Robinson T (2005) Vascular parkinsonism-an important cause of parkinsonism in older people. Age Ageing 34:114-119
9. Gerschlager W, Benesits G, Pirker W, Bloem BR, Asenbaum S, Prayer D, Zijlmans JC, Hoffmann M, Brucke T (2002) [123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease. Mov Disord 17:518-523
10. Plotkin M, Amthauer H, Klaffke S, Kuhn A, Ludemann L, Arnold G, Wernecke KD, Kupsch A, Felix R, Venz S (2005) Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients. J Neural Transm 112:677-692